The Polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs

被引:64
作者
Inoue, D
Sagata, N
机构
[1] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan
[2] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
关键词
cell cycle; fertilization; Myt1; Plk1; p90(rsk);
D O I
10.1038/sj.emboj.7600567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the meiotic cell cycle in Xenopus oocytes, p90(rsk), the downstream kinase of the Mos - MAPK pathway, interacts with and inhibits the Cdc2 inhibitory kinase Myt1. However, p90(rsk) is inactivated after fertilization due to the degradation of Mos. Here we show that the Polo- like kinase Plx1, instead of p90(rsk), interacts with and inhibits Myt1 after fertilization of Xenopus eggs. At the M phase of the embryonic cell cycle, Cdc2 phosphorylates Myt1 on Thr478 and thereby creates a docking site for Plx1. Plx1 can phosphorylate Myt1 and inhibit its kinase activity both in vitro and in vivo. The interaction between Myt1 and Plx1 is required, at least in part, for normal embryonic cell divisions. Finally, and interestingly, Myt1 is phosphorylated on Thr478 even during the meiotic cell cycle, but its interaction with Plx1 is largely inhibited by p90(rsk)-mediated phosphorylation. These results indicate a switchover in the Myt1 inhibition mechanism at fertilization of Xenopus eggs, and strongly suggest that Plx1 acts as a direct inhibitory kinase of Myt1 in the mitotic cell cycles in Xenopus.
引用
收藏
页码:1057 / 1067
页数:11
相关论文
共 50 条
  • [21] A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
    Abdelfatah, Sara
    Berg, Angela
    Boeckers, Madeleine
    Efferth, Thomas
    JOURNAL OF ADVANCED RESEARCH, 2019, 16 : 145 - 156
  • [22] Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1
    Raab, Monika
    Kraemer, Andrea
    Hehlgans, Stephanie
    Sanhaji, Mouraol
    Kurunci-Csacsko, Elisabeth
    Doetsch, Christina
    Bug, Gesine
    Ottmann, Oliver
    Becker, Sven
    Pachl, Fiona
    Kuster, Bernhard
    Strebhardt, Klaus
    MOLECULAR ONCOLOGY, 2015, 9 (01) : 140 - 154
  • [23] Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer
    Ahmad, N
    FASEB JOURNAL, 2004, 18 (01) : 5 - 7
  • [24] Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
    Chilamakuri, Rameswari
    Rouse, Danielle Crystal
    Agarwal, Saurabh
    PHARMACEUTICALS, 2022, 15 (05)
  • [25] Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds
    Abdelfatah, Sara
    Fleischer, Edmond
    Klinger, Anette
    Wong, Vincent Kam Wai
    Efferth, Thomas
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 1 - 9
  • [26] Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds
    Sara Abdelfatah
    Edmond Fleischer
    Anette Klinger
    Vincent Kam Wai Wong
    Thomas Efferth
    Investigational New Drugs, 2020, 38 : 1 - 9
  • [27] Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1
    Junaid, Asad
    Moon, Michael C.
    Harding, Gregory E. J.
    Zahradka, Peter
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (02): : C919 - C926
  • [28] The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors
    Moore, Xavier T. R.
    Gheghiani, Lilia
    Fu, Zheng
    CELLS, 2023, 12 (09)
  • [29] Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma
    Nappi, Tito Claudio
    Salerno, Paolo
    Zitzelsberger, Horst
    Carlomagno, Francesca
    Salvatore, Giuliana
    Santoro, Massimo
    CANCER RESEARCH, 2009, 69 (05) : 1916 - 1923
  • [30] Fate of primary cells at the G1/S boundary after polo-like kinase 1 inhibition by SBE13
    Keppner, Sarah
    Proschak, Ewgenij
    Schneider, Gisbert
    Spaenkuch, Birgit
    CELL CYCLE, 2011, 10 (04) : 708 - 720